We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.32B
AUM Growth
-$159M
Cap. Flow
-$268M
Cap. Flow %
-6.19%
Top 10 Hldgs %
53.32%
Holding
157
New
15
Increased
45
Reduced
34
Closed
12

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$203M
2
FCX icon
Freeport-McMoran
FCX
+$106M
3
ALLY icon
Ally Financial
ALLY
+$84.9M
4
FDX icon
FedEx
FDX
+$78.3M
5
LPX icon
Louisiana-Pacific
LPX
+$59.7M

Sector Composition

Rank Sector Weight
1 Industrials 23.93%
2 Consumer Discretionary 20.51%
3 Technology 19.89%
4 Materials 10.93%
5 Healthcare 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIG icon
51
Signet Jewelers
SIG
$3.76B
$7.49M 0.17%
92,721
CVNA icon
52
Carvana
CVNA
$77.9B
$7.48M 0.17%
123,850
-25,685
-17% -$1.4M
BIO icon
53
Bio-Rad Laboratories Class A
BIO
$9.42B
$7.45M 0.17%
11,559
+3,978
+52% +$2.42M
ALBO
54
DELISTED
Albireo Pharma Inc
ALBO
$7.24M 0.17%
205,892
+142,771
+226% +$4.64M
GRUB
55
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$7.18M 0.17%
+393,363
New +$42.3M
CTMX icon
56
CytomX Therapeutics
CTMX
$754M
$6.82M 0.16%
1,078,103
+292,204
+37% +$2.28M
MSFT icon
57
Microsoft
MSFT
$3.71T
$6.77M 0.16%
24,998
COGT icon
58
Cogent Biosciences
COGT
$7.24B
$6.7M 0.16%
826,119
+94,216
+13% +$796K
ASMB icon
59
Assembly Biosciences
ASMB
$529M
$6.41M 0.15%
137,751
+18,491
+16% +$916K
HCM icon
60
HUTCHMED
HCM
$2.17B
$6.21M 0.14%
158,054
+16,365
+12% +$473K
XGN icon
61
Exagen
XGN
$166M
$6M 0.14%
400,000
PRTA icon
62
Prothena Corp
PRTA
$450M
$5.24M 0.12%
101,905
-26,318
-21% -$821K
ADI icon
63
Analog Devices
ADI
$190B
$5.21M 0.12%
30,284
+12,139
+67% +$1.94M
IDYA icon
64
IDEAYA Biosciences
IDYA
$3.56B
$4.8M 0.11%
228,721
+35,598
+18% +$731K
MRUS
65
DELISTED
Merus
MRUS
$4.53M 0.1%
214,974
ALKS icon
66
Alkermes
ALKS
$8.25B
$4.46M 0.1%
182,086
+19,370
+12% +$431K
PVLA
67
Palvella Therapeutics
PVLA
$2.27B
$4.46M 0.1%
14,559
+8,199
+129% +$1.8M
MYOV
68
DELISTED
Myovant Sciences Ltd.
MYOV
$4.45M 0.1%
195,211
-28,872
-13% -$607K
INBX
69
DELISTED
Inhibrx, Inc. Common Stock
INBX
$4.28M 0.1%
155,401
CLF icon
70
Cleveland-Cliffs
CLF
$6.99B
$4.14M 0.1%
+191,837
New +$3.78M
IMTX icon
71
Immatics
IMTX
$1.32B
$3.86M 0.09%
332,356
+103,396
+45% +$1.21M
PYPL icon
72
PayPal
PYPL
$50.5B
$3.67M 0.08%
12,599
HOWL icon
73
Werewolf Therapeutics
HOWL
$19.3M
$3.61M 0.08%
+206,915
New +$2.83M
ZYME icon
74
Zymeworks
ZYME
$1.67B
$3.57M 0.08%
102,944
TKNO icon
75
Alpha Teknova
TKNO
$347M
$3.56M 0.08%
+150,000
New +$3.8M

Similar funds

Platinum Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Platinum Investment Management held 157 positions worth $4.32B, down 3.5% from $4.48B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Platinum Investment Management withdrew a net $268M in Q2 2021, closing 12 positions and reducing 34 holdings. Its most notable exit was Five Prime Therapeutics, Inc., an estimated $6.89M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Platinum Investment Management opened a new position in TAL Education Group worth $32.7M.

  • Platinum Investment Management's largest Q2 2021 buy was TAL Education Group: 1,297,317 shares worth $32.7M.
  • Platinum Investment Management added most to ZTO Express in Q2 2021, an estimated $152M increase.
  • Platinum Investment Management's biggest Q2 2021 reduction was GE Aerospace, cutting an estimated $203M.
  • Platinum Investment Management fully exited Five Prime Therapeutics, Inc. in Q2 2021, selling an estimated $6.89M.
  • Platinum Investment Management's ten largest holdings make up 53% of its $4.32B portfolio in Q2 2021.
  • Platinum Investment Management opened 15 new positions and closed 12 in Q2 2021.
  • Platinum Investment Management's portfolio value fell 3.5% quarter-over-quarter to $4.32B.

Based on Platinum Investment Management's 13F filing for Q2 2021, filed 11 Aug 2021.